SEPTAX 1 G

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
CEFTAZIDIME AS PENTAHYDRATE
Available from:
BIOAVENIR LTD, ISRAEL
ATC code:
J01DD
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJ/INF
Composition:
CEFTAZIDIME AS PENTAHYDRATE 1000 MG
Administration route:
I.M, I.V
Prescription type:
Required
Manufactured by:
VIANEX S.A, GREECE
Therapeutic group:
THIRD GENERATION CEPHALOSPORINS
Therapeutic indications:
Septax is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• Nosocomial pneumonia• Broncho-pulmonary infections in cystic fibrosis• Bacterial meningitis• Chronic suppurative otitis media• Malignant otitis externa• Complicated urinary tract infections• Complicated skin and soft tissue infections• Complicated intra-abdominal infections• Bone and joint infections• Peritonitis associated with dialysis in patient on CAPD.Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.Ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.Ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (TURP).The selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restric
Authorization number:
135 96 31243 00
Authorization date:
2011-12-31

Similar products

Search alerts related to this product

View documents history

Share this information